Amarin Corp Plcuk (AMRN) Prepaid Assets (2010 - 2026)
Amarin Corp Plc\Uk (AMRN) posted quarterly Prepaid Assets of $30.9 million for Q2 2026, up 77.27% year-over-year from $17.4 million in Q2 2025, and up 17.3% quarter-over-quarter from $26.4 million in Q1 2026.
Amarin Corp Plcuk (AMRN) Prepaid Assets (2010 - 2026) Analysis & Trends
Amarin Corp Plc\Uk (AMRN) has reported Prepaid Assets for 17 consecutive years, with $30.9 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Prepaid Assets rose 77.27% year-over-year to $30.9 million; the TTM figure through Jun 2026 stood at $30.9 million (up 77.27% YoY), while the FY2025 annual figure was $24.3 million, up 93.99% from the prior year.
- Prepaid Assets grew to $30.9 million in Q2 2026 per AMRN's latest filing, from $26.4 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $43.3 million in Q2 2023 and bottomed at $7.3 million in Q3 2024.
- Historically, Prepaid Assets has averaged $23.0 million across 5 years, with a median of $24.5 million in 2025.
- Annual changes were most pronounced in 2024 — Prepaid Assets tumbled 62.41% — and 2025, when it jumped 302.32%.
- Amarin Corp Plc\Uk's Prepaid Assets stood at $19.5 million in 2022, then tumbled by 40.4% to $11.6 million in 2023, then grew by 8.04% to $12.6 million in 2024, then soared by 93.99% to $24.3 million in 2025, then advanced by 26.97% to $30.9 million in 2026.
- Business Quant data shows AMRN's Prepaid Assets at $30.9 million in Q2 2026, $26.4 million in Q1 2026, and $24.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Amarin Corp Plcuk | 5.86 Bn | 5.54 Bn | 14.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.92 Mn |
| Mar 31, 2026 | 26.36 Mn |
| Dec 31, 2025 | 24.35 Mn |
| Sep 30, 2025 | 29.43 Mn |
| Jun 30, 2025 | 17.44 Mn |
| Mar 31, 2025 | 24.75 Mn |
| Dec 31, 2024 | 12.55 Mn |
| Sep 30, 2024 | 7.32 Mn |
| Jun 30, 2024 | 31.55 Mn |
| Mar 31, 2024 | 8.14 Mn |
| Dec 31, 2023 | 11.62 Mn |
| Sep 30, 2023 | 19.46 Mn |
| Jun 30, 2023 | 43.31 Mn |
| Mar 31, 2023 | 19.88 Mn |
| Dec 31, 2022 | 19.49 Mn |
| Sep 30, 2022 | 27.91 Mn |
| Jun 30, 2022 | 32.26 Mn |
| Mar 31, 2022 | 28.09 Mn |
| Dec 31, 2021 | 22.35 Mn |
| Sep 30, 2021 | 21.35 Mn |